Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus

被引:3
作者
Awasthi, Smita [1 ]
Daverey, Amita [1 ]
Dwivedi, Anila [1 ]
机构
[1] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India
关键词
ormeloxifene; estrogen receptor; AP-1; pathway;
D O I
10.1016/j.jsbmb.2007.03.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ormeloxifene is a selective estrogen receptor modulator that exerts antiestrogenic effects and thereby inhibits growth in uterus. The present study was undertaken to examine the AP-1 protein interaction with AP-1 enhancer DNA elements in rat uterus in vivo and in vitro with a view to explore the modulation of estrogen action mediated via alternative pathway under the influence of ormeloxifene (Orm). In addition, the changes in expression of c-fos and c-jun transcription factors and mRNA expression of growth factor (IGF-1) were investigated with a view to assess the AP-1 mediated transcription. Ovariectomizedoung adult rats were administered with estradiol-17 beta (5 mu g/100 g body weight) or Orm (200 mu g/100 g body weight) or vehicle for 3 days and sacrificed on fourth day. Electrophoretic mobility shift assay using uterine nuclear fraction from various treatment groups demonstrated that Orm caused a significant reduction in E-2 induced AP-1 DNA binding. In vitro study revealed that Orm promotes AP-1 complex formation whereas its 7-hydroxy derivative inhibits it significantly. Uterine expression of c-fos and c-jun was increased significantly in Orm treated rats as compared to vehicle treated rats. However, the expression of c-fos and c-jun was decreased in rats receiving Orm plus E-2. Semi-quantitative RT-PCR analysis revealed that mRNA expression of IGF-1 was increased in E-2 treated group as compared to control group whereas reduced expression was observed in Orm treated rats as compared to E-2 treated rats. The uterine weight and IGF-1 mRNA showed similar pattern, indicating that IGF-1 is involved in regulation of uterine weight. These results indicate that 7-hydroxy ormeloxifene (an active metabolite of Orm) is a potent antagonist at AP-1 sites. It inhibits the function of AP-1 transcription factors rather than their expression as evident by downregulation of mRNA expression of AP-1 regulated gene IGF-1, thereby inhibits proliferation in rat uterus. Study suggested a non-classicalregulation of estrogen action on uterus by ormeloxifene. (c) 2007 Published by Elsevier Ltd.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 33 条
[1]  
ARSHA M, 2004, J STEROID BIOCHEM, V19, P67
[2]  
BAIN SD, 1997, J BONE MINER RES S1, V12
[3]   Modulation of estrogen receptor transactivation and estrogen-induced gene expression by ormeloxifene - A triphenylethylene derivative [J].
Blesson, Chellakkan S. ;
Awasthi, Smita ;
Kharkwal, Geetika ;
Daverey, Amita ;
Dwivedi, Anila .
STEROIDS, 2006, 71 (11-12) :993-1000
[4]  
Clark JH, 1992, TXB ENDOCRINOLOGY, P35
[5]   BIOLOGICAL PROFILE OF 2-[4-(2-N-PIPERIDINOETHOXY)PHENYL]-3-PHENYL (2H) BENZO (B) PYRAN - A POTENT ANTIIMPLANTATION AGENT IN RAT [J].
DHAR, JD ;
SETTY, BS ;
DURAN, S ;
KAPIL, RS .
CONTRACEPTION, 1991, 44 (04) :461-472
[6]   STRUCTURE-ACTIVITY RELATIONSHIP OF SOME 2,3-DIARYL-2H-1-BENZOPYRANS TO THEIR ANTI-IMPLANTATION, ESTROGENIC AND ANTIESTROGENIC ACTIVITIES IN RAT [J].
DHAR, JD ;
DWIVEDI, A ;
SRIVASTAVA, A ;
SETTY, BS .
CONTRACEPTION, 1994, 49 (06) :609-616
[7]   Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene [J].
Dwivedi, A ;
Basu, R ;
Chowdhury, SR ;
Goyal, N .
CONTRACEPTION, 2005, 71 (06) :458-464
[8]   ACTIVATION OF THE OVALBUMIN GENE BY THE ESTROGEN-RECEPTOR INVOLVES THE FOS-JUN COMPLEX [J].
GAUB, MP ;
BELLARD, M ;
SCHEUER, I ;
CHAMBON, P ;
SASSONECORSI, P .
CELL, 1990, 63 (06) :1267-1276
[9]  
Goldman PS, 1997, RECENT PROG HORM RES, V52, P103
[10]  
KAMBOJ VP, 1977, INDIAN J EXP BIOL, V15, P1144